- Table of Contents
- List of Tables
- List of Figures
- Global Hepatitis E Pipeline Overview
- Key Findings, 2019
- Disease Overview
- Report Guide and Research Methodology

- Executive Summary
- Hepatitis E Drugs under active development, H1- 2019
- Pipeline Drugs in Early Stage of Development (Pre-clinical, Discovery, Phase 1 and Phase 2)
- Pipeline Drugs in Advanced Stage of Development (Phase 3, Pre-registration)
- Companies involved in Hepatitis E pipeline, H1- 2019
- Mechanism of Action wise Hepatitis E Pipeline Candidates

- Chongqing Zhifei Biological Products Co Ltd Hepatitis E Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- CPL Biologicals Pvt Ltd Hepatitis E Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments

- Gilead Sciences Inc Hepatitis E Pipeline Details
- Business Profile
- Drug Details
• Drug Snapshot
• Originator
• Collaborator/Co-Developer
• Route of Administration
• Orphan Drug/Fast Track/Special Designation
• Area
• Type of Molecular Entity
- Current Status
- Drug Overview
- Drug Mechanism of Action
- Clinical/Pre-clinical Trial Details
- Latest Drug Developments
- Latest Hepatitis E Drug Pipeline Developments, 2019

- Appendix
- About Us
- Sources and Methodology
- Contact Information